首页> 外文OA文献 >Immediate posttransplantation Cotrimoxazole-induced immune thrombocytopenia
【2h】

Immediate posttransplantation Cotrimoxazole-induced immune thrombocytopenia

机译:立即移植后复方新诺明引起的免疫性血小板减少症

摘要

Drug-induced immune thrombocytopenia (DITP) can be caused by numerous drugs. When this condition develops, platelet destruction results from binding of antibodies to normal platelets only in the presence of a sensitizing drug. A recently proposed model suggests that these drug-dependent antibodies are derived from a pool of naturally occurring antibodies with weak affinity for specific epitopes on certain platelet membrane glycoproteins. We describe here a case of DITP secondary to cotrimoxazole exposure in the immediate posttransplantation phase in a renal transplant recipient. Apart from heparin-induced thrombocytopenia, DITP posttransplantation has to the best of our knowledge never been described, perhaps because of its immune-mediated origin. Our case demonstrates that DITP can occur posttransplantation, that cotrimoxazole due to its intensive use in the transplanted population is one of the most likely causative agents and that a timely recognition and treatment might have important consequences for both graft and patient.
机译:药物诱导的免疫性血小板减少症(DITP)可以由多种药物引起。当这种情况发展时,仅在敏化药物存在下,抗体与正常血小板的结合才导致血小板破坏。最近提出的模型表明,这些药物依赖性抗体衍生自对某些血小板膜糖蛋白上的特定表位具有弱亲和力的天然存在的抗体库。我们在这里描述了肾脏移植受者在移植后即刻阶段继cotrimoxazole暴露后继发的DITP病例。除了肝素引起的血小板减少,据我们所知,DITP移植后从未被描述过,这可能是由于其免疫介导的起源。我们的案例表明,DITP可能在移植后发生,由于可曲唑在移植人群中的大量使用是最可能的病原体之一,及时识别和治疗可能对移植物和患者都有重要影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号